PARS: Postoperative Activity Restrictions After Slings

Sponsor
Northwell Health (Other)
Overall Status
Recruiting
CT.gov ID
NCT04552457
Collaborator
(none)
188
1
2
26.8
7

Study Details

Study Description

Brief Summary

Postoperative restrictions are often based on expert opinion and "common sense". There is a wide variety in the recommended activity limitation amongst pelvic floor surgeons. Many patients undergo urogynecologic procedures to improve their quality of life, and these additional restrictions decrease their quality of life in the short term. Our hypothesis is that unrestricted activity after a mid-urethral sling will not negatively impact a patient's recovery or likelihood of surgical success.

Eligible participants will be randomized to no postoperative instructions or traditional postoperative instructions. Patients will be followed up at 2 weeks, 6 weeks, and 6 months postoperatively. Data will be collected throughout the follow up period, but the primary endpoint is at 6 months. At the 6 month visit, subjects' activity level, leakage symptoms, and postoperative satisfaction will be assessed.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: No activity restrictions
  • Behavioral: Activity restrictions
N/A

Detailed Description

There is a limited body of literature regarding restrictions for gynecologic surgery. Most of these studies have looked at patients with prolapse and incontinence, and many of the postoperative recommendations are intended for both classes of procedures. Most surgeons restrict their patients' activities postoperatively but to varying degrees and for variable amounts of time. One study in 2017 showed no adverse effect on short term outcomes after prolapse repair with liberal postoperative restrictions compared to stricter, traditional restrictions. No studies have been performed to look at postoperative restrictions after mid-urethral slings.

A common reason for limiting activity is due to the unproven concern about increased intra-abdominal pressure on healing and surgical success. At this time, no studies have shown causality. The range of intra-abdominal pressures generated during "unavoidable" activities, such as coughing, standing, and bending, overlaps with the range of pressures generated during activities that are typically restricted. Another study showed the intra-abdominal pressures generated during activities of daily living overlapped with pressures generated by women performing CrossFit exercises.

A 2017 study showed no effect on outcomes with unrestricted activity after pelvic reconstructive surgery. Orthopedic literature suggests better outcomes with early postoperative activity over immobilization. There is a significant body of literature showing potential detrimental effects of sedentary behavior and bed rest.

In 2010, an estimated 28.1 million women had urinary incontinence; however only 260,000 sling surgeries were performed that year. As stress urinary incontinence is primarily thought to result from a loss of support for the urethra, anatomic repair key to its treatment. Many women delay any type of treatment for stress urinary incontinence due to lack of awareness or belief in the myth that stress incontinence is a "normal part of aging". The arbitrary activity restrictions serve as yet another obstacle to treatment, especially for women who work as physical laborers. Since these activity restrictions are rooted in medical dogma and there is no evidence supporting the necessity of postoperative activity restrictions, this is a significant, iatrogenic barrier to care for all women with stress urinary incontinence. Our study could provide objective evidence of the effects of activity on satisfaction and surgical success after mid-urethral slings.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
188 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Do Liberal Versus Strict Postoperative Restrictions After Mid-urethral Slings Affect Outcomes?
Actual Study Start Date :
Aug 7, 2020
Anticipated Primary Completion Date :
Jun 30, 2022
Anticipated Study Completion Date :
Nov 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: No activity restrictions

Behavioral: No activity restrictions
Patients in the "No activity restrictions" group will be allowed to return to their normal activity immediately.

Active Comparator: Activity restrictions

Behavioral: Activity restrictions
Patients in the "Activity restrictions" group will not be allowed to perform strenuous exercise or lift anything greater than 10lbs. "Strenuous exercise" will be defined as is any activity that requires so much exertion that one cannot have a conversation comfortably while doing it.

Outcome Measures

Primary Outcome Measures

  1. Patient satisfaction with postoperative course [6 months]

    5-point scale with minimum of 1 and maximum of 5 points, higher scores corresponding to more satisfaction

Secondary Outcome Measures

  1. Surgical success [6 months]

    Presence of persistent or recurrent stress urinary incontinence as defined as positive cough stress test and positive response on Urogenital Distress Inventory short form.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 85 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Aged 18-85 years

  • Urodynamic-proven stress incontinence or stress leakage on physical exam

  • Desires surgical management for stress incontinence with a midurethral sling

Exclusion Criteria:
  • Prior midurethral sling or urethropexy

  • Prior pelvic reconstruction

  • Prior pelvic radiation

  • Connective tissue disorder

  • Severe physical limitation at baseline

  • Currently pregnant or desires future childbearing potential

  • Concomitant surgeries (except for anterior colporrhaphy for anterior wall prolapse less than 0 on POPQ or other minor procedures).

Contacts and Locations

Locations

Site City State Country Postal Code
1 North Shore University Hospital Great Neck New York United States 11030

Sponsors and Collaborators

  • Northwell Health

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Northwell Health
ClinicalTrials.gov Identifier:
NCT04552457
Other Study ID Numbers:
  • 20-0141
First Posted:
Sep 17, 2020
Last Update Posted:
Jun 14, 2022
Last Verified:
Jun 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Northwell Health
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 14, 2022